U.S. News reviewed telehealth platforms that offer GLP-1 medications, some of which may provide both FDA-approved medications as well as compounded medications. Compounded medications have not ...

Gone are the days of battling obesity with a limited toolbox. With more weight loss supplements and drugs on the market than ever before, deciding which medication is right for you isn't as simple as ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The metabolic benefits of strength training may begin long before ...

Not losing weight on Zepbound may be related to not yet reaching the highest maintenance dose for your body, or to not increasing your activity level. You may not lose a significant amount of weight ...

Dosage adjustments for GLP-1s are a typical part of treatment, helping the body adapt and minimize side effects while optimizing weight-loss benefits. Doctors may increase your GLP-1 dose if weight ...

Rucking is walking for a set distance with a weighted vest or backpack on your back. It started in the military. Soldiers march carrying heavy loads on their backs to train for carrying heavy ...

Chelsea Rae Bourgeois is a health writer and registered dietitian nutritionist with over eight years of experience in the clinical setting. Her writing covers nutrition and overall health topics, ...

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. Both cardio and weight ...

Just seven days of strength training increased visceral fat burning in obese mice, even before any weight loss could be seen on a scale. In an experiment conducted at the State University of Campinas ...

If you told me 50 years ago that I’d be lifting heavier than ever and feeling my most energetic at 71, I never would’ve believed you—but here I am. I’ve always been active, but when the COVID-19 ...

Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...